Creative Planning’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19M Buy
265,065
+22,362
+9% +$1.72M 0.01% 466
2025
Q4
$19.3M Buy
242,703
+57,084
+31% +$4.5M 0.01% 398
2025
Q3
$14M Sell
185,619
-2,218
-1% -$152K 0.01% 460
2025
Q2
$13M Sell
187,837
-45,056
-19% -$2.95M 0.01% 450
2025
Q1
$15.8M Buy
232,893
+16,490
+8% +$987K 0.01% 370
2024
Q4
$9.71M Sell
216,403
-34,488
-14% -$1.93M 0.01% 455
2024
Q3
$15.8M Buy
250,891
+47,737
+23% +$2.79M 0.02% 325
2024
Q2
$12M Sell
203,154
-51,042
-20% -$3.19M 0.01% 366
2024
Q1
$20.3M Buy
254,196
+17,111
+7% +$1.31M 0.02% 259
2023
Q4
$18.7M Sell
237,085
-8,454
-3% -$602K 0.03% 246
2023
Q3
$17.1M Buy
245,539
+61,205
+33% +$4.34M 0.02% 260
2023
Q2
$12.7M Buy
184,334
+9,656
+6% +$687K 0.02% 300
2023
Q1
$13M Sell
174,678
-5,424
-3% -$455K 0.02% 287
2022
Q4
$16.8M Buy
180,102
+9,816
+6% +$947K 0.03% 237
2022
Q3
$16.2M Sell
170,286
-4,083
-2% -$404K 0.03% 215
2022
Q2
$16.2M Buy
174,369
+33,675
+24% +$3.29M 0.03% 227
2022
Q1
$14.2M Buy
140,694
+10,688
+8% +$1.12M 0.02% 266
2021
Q4
$13.4M Sell
130,006
-795
-0.6% -$73.5K 0.02% 238
2021
Q3
$11.1M Sell
130,801
-6,343
-5% -$531K 0.02% 248
2021
Q2
$11.4M Sell
137,144
-17,286
-11% -$1.42M 0.02% 246
2021
Q1
$11.6M Sell
154,430
-3,917
-2% -$285K 0.02% 246
2020
Q4
$10.8M Buy
158,347
+31,054
+24% +$2.02M 0.02% 243
2020
Q3
$7.43M Buy
127,293
+4,202
+3% +$261K 0.02% 261
2020
Q2
$8M Sell
123,091
-1,068
-0.9% -$67.3K 0.02% 216
2020
Q1
$7.37M Sell
124,159
-2,052
-2% -$137K 0.03% 205
2019
Q4
$9.38M Sell
126,211
-9,704
-7% -$681K 0.03% 202
2019
Q3
$8.57M Sell
135,915
-15,985
-11% -$947K 0.03% 202
2019
Q2
$8.28M Buy
151,900
+8,719
+6% +$470K 0.03% 207
2019
Q1
$7.72M Buy
143,181
+3,490
+2% +$215K 0.03% 208
2018
Q4
$9.15M Buy
139,691
+16,757
+14% +$1.25M 0.04% 158
2018
Q3
$9.68M Buy
122,934
+20,317
+20% +$1.45M 0.04% 170
2018
Q2
$6.6M Buy
102,617
+9,042
+10% +$596K 0.03% 210
2018
Q1
$5.82M Sell
93,575
-3,001
-3% -$215K 0.02% 218
2017
Q4
$7M Buy
96,576
+6,009
+7% +$437K 0.03% 182
2017
Q3
$7.37M Sell
90,567
-4,921
-5% -$389K 0.03% 178
2017
Q2
$7.68M Buy
95,488
+4,561
+5% +$360K 0.04% 167
2017
Q1
$7.14M Buy
90,927
+1,421
+2% +$113K 0.04% 171
2016
Q4
$7.06M Sell
89,506
-4,487
-5% -$363K 0.04% 167
2016
Q3
$8.36M Buy
93,993
+11,012
+13% +$1.04M 0.05% 138
2016
Q2
$7.95M Buy
82,981
+1,520
+2% +$151K 0.06% 123
2016
Q1
$8.45M Sell
81,461
-6,092
-7% -$592K 0.07% 110
2015
Q4
$8.56M Buy
87,553
+2,182
+3% +$214K 0.07% 113
2015
Q3
$8.24M Buy
85,371
+2,491
+3% +$262K 0.07% 112
2015
Q2
$8.69M Buy
82,880
+306
+0.4% +$31.3K 0.08% 106
2015
Q1
$8.52M Buy
82,574
+15,347
+23% +$1.55M 0.08% 105
2014
Q4
$6.47M Buy
67,227
+16,226
+32% +$1.43M 0.07% 123
2014
Q3
$4.06M Buy
51,001
+873
+2% +$68.8K 0.05% 150
2014
Q2
$3.78M Buy
50,128
+3,921
+8% +$296K 0.05% 146
2014
Q1
$3.46M Buy
46,207
+1,185
+3% +$83.7K 0.05% 132
2013
Q4
$3.22M Buy
45,022
+3,382
+8% +$217K 0.06% 130
2013
Q3
$2.36M Buy
41,640
+5,980
+17% +$356K 0.05% 130
2013
Q2
$2.04M Buy
+35,660
New +$2.07M 0.05% 130

Other funds holding CVS

Creative Planning's CVS Position: Q1 2026 in Review

Creative Planning increased its CVS Health (CVS) stake by 9.2% in Q1 2026, buying an estimated $1.72M and bringing the position to 265,065 shares worth $19M. The position accounts for 0.01% of the portfolio, ranked #466.

Creative Planning first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.3M in Q1 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Creative Planning held 265,065 shares of CVS Health worth $19M as of Q1 2026.
  • Creative Planning bought 22,362 CVS Health shares in Q1 2026, an estimated $1.72M.
  • CVS Health made up 0.01% of Creative Planning's portfolio in Q1 2026, its #466 holding.
  • Creative Planning first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Creative Planning's CVS Health position peaked at $20.3M in Q1 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.